Continuing Education Information
Full Conference Agenda
Sessions on Tuesday, November 9 are eligible for 4.25 ACPE credits. Sessions on Wednesday, November 10 are eligible for 3.25 ACPE credits.
Educational Grants:
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
This educational activity is supported by an educational grant from GlaxoSmithKline.
This activity is supported by an educational grant from Lilly.
Disclosure Information
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors, and anyone who may be in control of content have been mitigated.
Planners/Speakers:
Dave Hughes, CME Course Advisor, Boston University School of Medicine CME/CNE Office, has received grant/research support from Rigel Pharmaceuticals and is on the AbbVie and Amgen Speaker’s Bureaus.
Naomi Moeller and Mike Burk, Boston University School of Medicine CME/CNE Office, have no relevant financial relationships.
Carmela A. Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Boston University School of Medicine CME/CNE Office, has no relevant financial relationships.
Debra Patt, MD, PhD, MBA, FASCO is a consultant for Pfizer.
Regina Gibson-Burtnick, BBA, CAE, has no relevant financial relationships.
Christina Fuller, BSW has no relevant financial relationships
Johanna Garzon, MHA, HBAT has no relevant financial relationships.
Blair Irwin, MD has no relevant financial relationships.
Jeffrey Kendall Psy. D., LP is a speaker for Lilly Oncology and Pfizer Oncology.
Rebecca McMahon has no relevant financial relationships.
Kerri Michalik, MHA, BSN has no relevant financial relationships.
Krista Nelson, BSW is on the patient advisory board with Athenex Oncology.
Rebekkah Schear, MIA is a consultant for the European Institute of Innovation and Technology.
Barbara Schmidtman, PhD has no relevant financial relationships.
Sandra Megally has no relevant financial relationships.
Latha Shivakumar, PhD, CHCPD has no relevant financial relationships.
Monique Marino has no relevant financial relationships.
Leigh M. Boehmer, PharmD, BCOP is a consultant for Pfizer.
Maddelynne Parker, BA has no relevant financial relationships.
Nancy Bowles, MHA, RN, OCN, CRNI, NEA-BC, CPC, CHONC has no relevant financial relationships.
Mehmet Erkan Ceyhan PhD has no relevant financial relationships.
Jia Conway DNP, CRNP, AOCNP, has no relevant financial relationships.
Willliam Dale MD, PhD has no relevant financial relationships.
Nicholas Garland, MS has no relevant financial relationships.
Savannah Geske, PhD has no relevant financial relationships.
Michele Goodman RN, BSN, MBA has no relevant financial relationships.
Shakira Grant MBBS has no relevant financial relationships.
B. Lee Green, PhD has no relevant financial relationships.
Lauren Hamel, PhD has no relevant financial relationships.
Douglas Holt, MD has no relevant financial relationships.
Scott A. Kasper, MS has no relevant financial relationships.
Katie Klar RN, BSN has no relevant financial relationships.
Ponnandai Somasundar, MD is a consultant for Medtronic.
Lorna Mabunda has no relevant financial relationships.
Rachel Marquez, MPH has no relevant financial relationships.
Laura Matthews MBA, MPH has no relevant financial relationships.
Javier Munoz, MD, MS, MBA, FACP is a consultant for Pharmacyclics, received grant research support from Bayer, is a speaker for Gilead, and has received honoraria from Targeted Oncology, OncView, Curio, Kyowa, Physicians' Education Resource, and Seattle Genetics. He plans on discussing unlabeled/investigational uses of a commercial product.**
Amanda Parkes, MD is a consultant for Deciphera and Daiichi-Sankyo.
Debra Patt, MD, PhD, MBA is a consultant for Pfizer.
Lori J. Pierce, MD, FASTRO, FASCO receives patents from PFS Genomics/Exact Sciences, receives royalties from UpToDate and receives MROQC Salary from BCBSM.
Richard Schilsky, MD, FACP is a consultant for Bryogyx, Cellworks, Clarifed Precision Oncology, EQRx, and Scandion Oncology, receives grant research support from Astra-Zeneca, Bayer, Bristol Myers Squibb, Genetech, Lilly, Merck, Pfizer and Seattle Genetics. He plans on discussing unlabeled/investigational uses of a commercial product.**
**These faculty members plan on discussing unlabeled/investigational uses of a commercial product. All other faculty do not.
Accreditation
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the Association of Community Cancer Centers. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by the Association of Community Cancer Centers.
Contact Hours: 8.0
Pharmacists: The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 4.25 contact hours (0.425 CEUS) for Day One (11/9/2021) of the educational activity and 3.25 contact hours (0.325 CEUS) for Day Two (11/10/2021) of the educational activity. Day One UAN: 0060-9999-21-047-L01-P Day Two UAN: 0060-9999-21-048-L01-P.
Social Workers: This program is Approved by the National Association of Social Workers (Approval # 886791045-6518) for 2.5 continuing education contact hours.
If you have any questions, please contact the Continuing Education Department at 202-336-8295 or visit us on the Web at http://www.socialworkers.org/Careers/CE-Approval-Program. You can also email questions to CEU@socialworkers.org .
Learning Objectives
At the end of this educational activity, participants should be able to:
- Review strategies to help cancer practices recover from the global pandemic
- Describe how to implement a cancer care and community paramedicine partnership to reduce emergency visits
- Adopt an APP-physician model to improve risk stratification and palliative care
- Investigate the role of new technologies to enhance provider and patient interaction, improve patient education, and reduce financial toxicity
- Assess telehealth models for delivery of comprehensive cancer care services for special patient populations
- Integrate innovative approaches for identifying and solving transportation issues for patients to reduce no-show appointments
- Explore the importance of comprehensive cancer care services and how they are critical to providing quality, patient-centered, holistic care.
How to Claim CME/NCPD/Social Work Credit
CME/NCPD credit will be awarded to those that attend the 8-hour program and complete the evaluation. Social work credit will be awarded up to 2.5 contact hours to those that attend the sessions approved for social work credit. To claim CE credits, you must complete the post-session evaluation and print or save your certificate by 11:59 pm ET on December 9, 2021. Once you complete the evaluation, you will be able to claim your credits and print and save your certificate of completion. Learners should only claim credit commensurate with the extent of their participation in the activity
For questions about CME, please contact rburtnick@accc-cancer.org
How to Claim ACPE Credit
PROGRAM EVALUATION: All participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.
REQUIREMENTS FOR CE CREDIT: A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the program completion date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
Instructions for Completing a Program Evaluation and Reporting Pharmacy CE credit
1. Go to the University of Rhode Island College of Pharmacy Continuing Professional Development Learning Management System located at www.uripharmacycpd.org and create an account using your email address and pharmacy license number.* Enter all of the required account information. Verify that your date of birth and NABP ID Number are entered correctly. Click the “Update Account” button at the bottom of the page to save the account information.
2. Complete the program evaluations. Evaluations must be completed within 60 days of the program.
- Log onto www.uripharmacycpd.org
- Select Complete Live Activity Post-Test/Evaluations and select the program date and title of the activity (see below).
- Enter the program evaluation code and complete program evaluation.
- Select submit at the bottom of the page.
- You will receive a confirmation message of evaluation completion and notification that your CE data was reported to the CPE Monitor.
The evaluation access codes for this program are: “ACCC 38th Virtual National Oncology Conference”
November 9, 2021 (Day One): BUNLC38
November 10, 2021 (Day Two): BUNLC48
Disclaimer:
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS
